IL140069A0 - A method for assessing a diabetic's risk of experiencing a diabetes-associated pathologic condition - Google Patents

A method for assessing a diabetic's risk of experiencing a diabetes-associated pathologic condition

Info

Publication number
IL140069A0
IL140069A0 IL14006999A IL14006999A IL140069A0 IL 140069 A0 IL140069 A0 IL 140069A0 IL 14006999 A IL14006999 A IL 14006999A IL 14006999 A IL14006999 A IL 14006999A IL 140069 A0 IL140069 A0 IL 140069A0
Authority
IL
Israel
Prior art keywords
lysine
fructose
proteins
diabetic
disclosed
Prior art date
Application number
IL14006999A
Other languages
English (en)
Original Assignee
Fox Chase Cancer Ct
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fox Chase Cancer Ct filed Critical Fox Chase Cancer Ct
Publication of IL140069A0 publication Critical patent/IL140069A0/xx

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Diabetes (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Financial Or Insurance-Related Operations Such As Payment And Settlement (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL14006999A 1998-06-11 1999-06-10 A method for assessing a diabetic's risk of experiencing a diabetes-associated pathologic condition IL140069A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9595398A 1998-06-11 1998-06-11
PCT/US1999/013122 WO1999064561A2 (fr) 1998-06-11 1999-06-10 Procede permettant d'evaluer le risque du diabetique connaissant un etat pathologique associe aux diabetes

Publications (1)

Publication Number Publication Date
IL140069A0 true IL140069A0 (en) 2002-02-10

Family

ID=22254350

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14006999A IL140069A0 (en) 1998-06-11 1999-06-10 A method for assessing a diabetic's risk of experiencing a diabetes-associated pathologic condition

Country Status (10)

Country Link
EP (1) EP1085885B1 (fr)
JP (1) JP2002517738A (fr)
CN (1) CN1312721A (fr)
AT (1) ATE251308T1 (fr)
AU (1) AU743112B2 (fr)
CA (1) CA2334709A1 (fr)
DE (1) DE69911771D1 (fr)
HK (1) HK1039904A1 (fr)
IL (1) IL140069A0 (fr)
WO (1) WO1999064561A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7622117B2 (en) 2002-04-17 2009-11-24 Dynamis Therapeutics, Inc. 3-deoxyglucosone and skin
DE602005027246D1 (de) * 2004-11-25 2011-05-12 Meiji Dairies Corp Mittel zur linderung von niereninsuffizienz
CN110133296B (zh) * 2012-03-18 2022-03-25 镜株式会社 疾病样品分析装置、分析系统及分析方法
JP6189080B2 (ja) * 2012-04-25 2017-08-30 上野製薬株式会社 終末糖化産物生成抑制剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6004958A (en) * 1997-02-05 1999-12-21 Fox Chase Cancer Center Compounds and methods for therapeutic intervention in preventing diabetic complications and procedures for assessing a diabetic's risk of developing complications and determining the efficacy of therapeutic intervention
CN1331599A (zh) * 1998-10-28 2002-01-16 福克斯契思癌症中心 化合物及其用于治疗糖尿病并发症的用途

Also Published As

Publication number Publication date
JP2002517738A (ja) 2002-06-18
WO1999064561A3 (fr) 2000-02-03
ATE251308T1 (de) 2003-10-15
AU4678999A (en) 1999-12-30
EP1085885B1 (fr) 2003-10-01
EP1085885A2 (fr) 2001-03-28
CA2334709A1 (fr) 1999-12-16
AU743112B2 (en) 2002-01-17
DE69911771D1 (de) 2003-11-06
HK1039904A1 (zh) 2002-05-17
EP1085885A4 (fr) 2002-01-02
WO1999064561A2 (fr) 1999-12-16
CN1312721A (zh) 2001-09-12

Similar Documents

Publication Publication Date Title
CA2279428A1 (fr) Composes et procedes concernant l'utilisation d'agents therapeutiques dans la prevention de complications diabetiques
Bird et al. Metabolic homoeostasis of L-threonine in the normally-fed rat. Importance of liver threonine dehydrogenase activity
Erecińska et al. Regulation of GABA level in rat brain synaptosomes: fluxes through enzymes of the GABA shunt and effects of glutamate, calcium, and ketone bodies
Wong et al. Relationship between liver and kidney levels of glutathione and metallothionein in rats
Straka et al. Purification and characterization of bovine hepatic uroporphyrinogen decarboxylase
Fukino et al. Mechanism of protection by zinc against mercuric chloride toxicity in rats: effects of zinc and mercury on glutathionine metabolism
Valero et al. Kinetic study of the effect of metabisulfite on polyphenol oxidase
Andersson et al. Activation and inhibition of microsomal glutathione transferase from mouse liver
Goto et al. An improved method for determination of active and total renin concentration in human plasma using an excess of sheep substrate
Pegg Effect of α-difluoromethylornithine on cardiac polyamine content and hypertrophy
IL140069A0 (en) A method for assessing a diabetic's risk of experiencing a diabetes-associated pathologic condition
Reglero et al. Deacylation and transacetylation of acetyl glutamate and acetyl ornithine in rat liver
Cathelineau et al. Effect of propionate and pyruvate on citrulline synthesis and ATP content in rat liver mitochondria
Erman et al. Angiotensin converting enzyme activity in the serum, lung and kidney of diabetic rats
Ryzlak et al. Human brain glyceraldehyde‐3‐phosphate dehydrogenase, succinic semialdehyde dehydrogenase and aldehyde dehydrogenase isozymes: substrate specificity and sensitivity to disulfiram
Ronquist Zinc ion stimulation of ATP cleavage by prostasomes from human seminal plasma
Minuk et al. Changes in serum and hepatic polyamine concentrations after 30%, 70% and 90% partial hepatectomy in rats
Porter et al. Stability and activation of glutamate apodecarboxylase from pig brain
Sieg et al. Effect of alcohol on δ-aminolevulinic acid dehydratase and porphyrin metabolism in man
Walter et al. Induction of drug metabolizing enzymes by sulfinpyrazone
Fitzpatrick et al. A substrate‐induced change in the stereospecificity of the serine‐hydroxymethyltransferase‐catalysed exchange of the α‐protons of amino acids: Evidence for a second catalytic site
Backman-Gullers et al. Studies on lipoamidase: characterization of the enzyme in human serum and breast milk
Zilberman et al. The effect of verapamil, lanthanum and local anesthetics on serotonin release from rabbit platelets
Orellana et al. Insights into the interaction of human liver arginase with tightly and weakly bound manganese ions by chemical modification and site-directed mutagenesis studies
Lijnen et al. Role of various vasodepressor systems in the acute hypotensive effect of captopril in man